Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Ethanol and Rimonabant

supplement:

Ethanol

Research Papers that Mention the Interaction

Rimonabant also reduced resumption of cocaine-seeking responses and may also reduce ethanol and opiate-seeking behavior.
Journal of Molecular Medicine  •  2013  |  View Paper
The cannabinoid CB(1) antagonist/inverse agonist rimonabant has been shown to reduce the behavioral effects of stimuli associated with drugs of abuse, including nicotine, alcohol , cocaine, and marijuana.
Current topics in behavioral neurosciences  •  2009  |  View Paper
Naloxone and rimonabant block neurotransmitter action of some drugs of abuse (such as ethanol , opiates, and nicotine), and thereby reduce drug seeking and self-administration by suppressing the drugs' reinforcing properties.
Experimental and clinical psychopharmacology  •  2011  |  View Paper
Thus, rimonabant possibly enhances an endogenous response generated by interrupting the regular use of alcohol.
Neuropharmacology  •  2008  |  View Paper
Rimonabant (0.0, 0.3, 1.0 and 3.0 mg/kg) significantly reduced ethanol self-administration.
Psychopharmacology  •  2008  |  View Paper
of single 2.5 and 5.0-mg/kg doses of rimonabant preferentially reduced ethanol intake, whereas a 10 mg/kg dose of rimonabant similarly reduced both ethanol and food intake.
Alcohol  •  2008  |  View Paper
Rimonabant (3 or 10 mg/kg) altered the locomotor effect of alcohol in a biphasic manner.
Behavioural Brain Research  •  2007  |  View Paper
These results suggest that rimonabant can prevent the relapse to alcohol , even when an interaction with nicotine exists-the most frequent situation in human alcohol abuse.
Neurobiology of Disease  •  2007  |  View Paper
Rimonabant may selectively reduce responding for an ethanol solution compared with an alternative.
Behavioural pharmacology  •  2006  |  View Paper
Antagonism of the CB(1) cannabinoid receptor (CB(1) receptor) by rimonabant (SR141716) reduces self-administration of alcohol and other drugs of abuse in animal models.
Brain Research  •  2006  |  View Paper